Specialty Pharmacy Innovation Starts at Booth #723.

Ready to shape the future of specialty pharmacy together? The countdown is on to NASP 2025 Annual Meeting & Expo in Denver, Sept. 14-17.

This year, we’re building on last year’s momentum with new continuing education (CE) sessions, breakthrough clinical outcomes research, and practical strategies to help health system specialty pharmacies (HSSPs) thrive.

Here’s a look at where you can connect with our specialty pharmacy experts throughout the week.

CE Session: How Pharmacists Are Bridging Social Health Gaps

Wednesday, September 17 | 12:20-1:10 p.m. MT | Maple 3

Supporting patients’ social determinants of health (SDOH) and health-related social needs (HRSNs) is among the most impactful activities for pharmacy teams. Studies show up to 50% of outcomes are driven by social, economic, and cultural factors while clinical care accounts for only 20%.

CPS leaders Lily Duong, PharmD, SVP of Clinical Development, and Shanece Green, PharmD, RPh, MSPH, MBA, Director of Health Equity will present “The Digital Bridge: Pharmacist Innovating Targeting Social Health Gaps.”

Key Learnings

-   How to use SDOH assessments to address the social and economic needs that can lead          to better outcomes.

-   What pharmacy teams are doing to help reduce disparities and enhance health equity.

-   Why technology is the key to addressing social health needs in practice.

Join us for the presentation on Wednesday, Sept. 17 at 12:20-1:10 p.m. MT in Maple 3.

Continuing education (CE) credit will be offered for qualified pharmacists.

Clinical Outcomes Research: 8 Posters Showcasing Specialty Pharmacy Impact

Tuesday, Sept. 16 | 2-3 p.m. MT | Aurora Exhibit Hall 2

This year, we’re proud to share eight clinical outcomes posters demonstrating how HSSPs are improving care, driving efficiency, and advancing health equity.

Key Findings

-   Pharmacist-led interventions enable earlier detection of rare and complex conditions.

-   Pharmacogenomic protocols improve medication safety and treatment outcomes.

-   Patient-reported outcome measures (PROMs) drive improvements for common chronic          conditions like asthma and migraine.

-   HSSPs are key to enhancing care for those who need it most.

Learn more about the research on Tuesday, Sept. 16 | 2-3 p.m. MT in Aurora Exhibit Hall 2. 

Outcomes Study: Health-System Specialty Pharmacists as Key Players in the Early Identification of Patients with Hereditary Amyloid Transthyretin Amyloidosis

Outcomes Study: Optimizing Care, Reducing Cost: The Impact of Health-System Specialty Pharmacists in Idiopathic Pulmonary Fibrosis Management

Outcomes Study: Utilization of a Health-System Specialty Pharmacy to Optimize Management of HCV-Positive Kidney Transplant Recipients

Outcomes Study: Implementing a Health-System Specialty Pharmacist-Led Pharmacogenomic Protocol for DPYD Genetic Testing to Optimize Capecitabine Safety

Outcomes Study: Improving Asthma Care Through Patient-Reported Outcome Measure Optimization

Outcomes Study: Development and Implementation of a Work Productivity and Activity Impairment Assessment Process for Employed Patients with Migraine in a Health-System Specialty Pharmacy Setting

Outcomes Study: Identifying and Addressing Nonadherence Risk with a Technology-Supported, Pharmacist-Led Risk Stratification Process at a Health-System Specialty Pharmacy

Outcomes Study: Technology-Driven Social Determinants of Health Screening for Patients with Neurological Conditions

From CE sessions to outcomes research, we look forward to working with you to help shape the future of specialty pharmacy. Let’s continue the conversation in Denver.

Meet the CPS team at Booth #723.